Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan

References

• Naleway AL, Davis ME, Greenlee RT, et al. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 2005;14:862-6
   PubMed Web of Science ®Google Scholar
• Uramoto KM, Michet CJ, Thumboo J, et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 1999;42:46-50
   PubMed Web of Science ®Google Scholar
• Balluz L, Philen R, Ortega L, et al. Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol 2001;154:1029-36
   PubMed Web of Science ®Google Scholar
• Chakravarty EF, Bush TM, Manzi S, et al. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007;56:2092-4
   PubMed Web of Science ®Google Scholar
• Bertsias GK, Salmon JE, Boumpas DT. Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 2010;69:1603-11
   PubMedGoogle Scholar
• Pons-Estel GJ, Alarcon GS, Scofield L, et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010;39:257-68
   PubMed Web of Science ®Google Scholar
• D’Cruz DP, Khamashta MA, Hughes GRV. Systemic lupus erythematosus. Lancet 2007;369:587-96
   PubMed Web of Science ®Google Scholar
• Carls G, Li T, Panopalis P, et al. Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis. J Occup Environ Med 2009;51:66-79
   PubMed Web of Science ®Google Scholar
• Campbell R, Jr Cooper GS, Gilkeson GS. Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: mortality risk and quality of life early in the course of disease. Arthritis Rheum 2008;59:458-64
   PubMed Web of Science ®Google Scholar
• Scofield L, Reinlib L, Alarcon GS, et al. Employment and disability issues in systemic lupus erythematosus: a review. Arthritis Rheum 2008;59:1475-9
   PubMed Web of Science ®Google Scholar
• Campbell R, Jr., Cooper GS, Gilkeson GS. The impact of systemic lupus erythematosus on employment. J Rheumatol 2009;36:2470-5
   PubMedGoogle Scholar
• McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;15:633-43
   PubMed Web of Science ®Google Scholar
• Mok CC, Ho LY, Cheung MY, et al. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Scand J Rheumatol 2009;38:121-7
   PubMed Web of Science ®Google Scholar
• Panopalis P, Tazdany J, Gillis JZ, et al. Health care costs and costs associated with change in work productivity among persons with systemic lupus erythematosus. Arthritis Rheum 2008;59:1788-95
   PubMedGoogle Scholar
• Yelin E, Tonner C, Trupin L, et al. Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample. Arthritis Rheum 2009;61:247-58
   PubMedGoogle Scholar
• Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550-7
   PubMed Web of Science ®Google Scholar
• Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003;56:481-90
   PubMed Web of Science ®Google Scholar
• Lau CS, Mak A. The socioeconomic burden of SLE. Nat Rev Rheumatol 2009;5:400-4
   PubMed Web of Science ®Google Scholar
• Isenberg DA, Allen E, Farewell V, et al. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis 2011;70:54-9
   PubMedGoogle Scholar
• Ruperto N, Hanrahan LM, Alarcon GS. International consensus for a definition of disease flare in lupus. Lupus 2011;20:453-62
   PubMed Web of Science ®Google Scholar
• Gladman DD, Urowitz MB, Rahman P, et al. Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 2003;30:1955-9
   PubMed Web of Science ®Google Scholar
• Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine 2006;85:147-56
   PubMed Web of Science ®Google Scholar
• Rivest C, Lew RA, Welsing PM, et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 2000;27:680-4
   PubMedGoogle Scholar
• Gladman DD, Urowitz MB, Kagal A, et al. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 2000;27:377-9
   PubMed Web of Science ®Google Scholar
• Kalunian K, Merrill JT. New directions in the treatment of systemic lupus erythematosus. Curr Med Res Opin 2009;25:1501-14
   PubMed Web of Science ®Google Scholar
• Zonana-Nacach A, Barr SG, Magder LS, et al. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000;43:1801-8
   PubMed Web of Science ®Google Scholar
• Zhu TY, Tam LS, Lee VW, et al. The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis Rheum 2009;61:1159-67
   PubMedGoogle Scholar
• Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40
   PubMed Web of Science ®Google Scholar
• Liang MH, Socher SA, Larson MG, et al. Reliability and validity of 6 systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18
   PubMed Web of Science ®Google Scholar
• Isenberg DS, Rahman A, Allen E, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group’s disease activity index for patients with systemic lupus arythematosus. Rheumatology 2005;44:902-6
   PubMed Web of Science ®Google Scholar
• Bureau of Labor Statistics. US Department of Labor, Consumer Price Index, Chained Consumer Price Index. Washington, DC. 2009 http://www.bls.gov/data/. Accessed 10 September 2009
   Google Scholar
• Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ 1999;1:153-71
   Google Scholar
• Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998;17:283-9
   PubMed Web of Science ®Google Scholar
• Pelletier EM, Ogale S, Yu E, et al. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database. Clin Ther 2009;31:2653-64
   PubMed Web of Science ®Google Scholar
• Li T, Carls GC, Panopalis P, et al. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large Medicaid population. Arthritis Rheum 2009;61:755-63
   PubMedGoogle Scholar
• Zhu TY, Tam LS, Lee VW, et al. Relationship between flare and health-related quality of life in patients with systemic lupus erythematosus. J Rheumatol 2010;37:568-73
   PubMed Web of Science ®Google Scholar
• Brunner HI, Sherrard TM, Klein-Gitelman MS. Cost of treatment of childhood-onset systemic lupus erythematosus. Arthritis Rheum 2006;55:184-8
   PubMedGoogle Scholar
• Urowitz MB, Gladman DD, Ibañez D, et al. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken) 2012;64:132-7
   PubMed Web of Science ®Google Scholar
• Sutcliffe N, Clarke AE, Taylor R, et al. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001;40:37-47
   PubMed Web of Science ®Google Scholar
• Zhu TY, Tam LS, Li EK. Cost-of-illness studies in systemic lupus erythematosus: a systematic review. Arthritis Care Res (Hoboken) 2011;63:751-60
   PubMed Web of Science ®Google Scholar
• Zhu TY, Tam LS, Lee VW, et al. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong. Rheumatology (Oxford) 2009;48:564-8
   PubMedGoogle Scholar